• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Sullivan James David bought $3,300 worth of shares (20,000 units at $0.17), increasing direct ownership by 5% to 388,171 units (SEC Form 4)

    12/4/23 8:35:57 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology
    Get the next $BKYI alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Sullivan James David

    (Last) (First) (Middle)
    C/O BIO-KEY INTERNATIONAL, INC.
    101 CRAWFORDS CORNER RD, SUITE 4116

    (Street)
    HOLMDEL NJ 07733

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    BIO KEY INTERNATIONAL INC [ BKYI ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) X Other (specify below)
    Chief Legal Officer / SVP Strategy & Compliance
    3. Date of Earliest Transaction (Month/Day/Year)
    11/30/2023
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 11/30/2023 P 20,000 A $0.165 388,171(1) D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Holdings do not include options to purchase 18,750 shares.
    /s/ James Sullivan 12/04/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $BKYI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BKYI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BKYI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • BIO-key Joins ISMS Forum to Advance Cybersecurity and Identity Management Best Practices in Spain

      MADRID and HOLMDEL, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication solutions, today announced that it has joined ISMS Forum, Spain's leading cybersecurity association dedicated to promoting information security, data protection, and risk management best practices. This collaboration reinforces BIO-key's expanding presence and commitment to enhancing cybersecurity resilience and contributing to the development of robust security strategies for organizations across Spain. Through its ISMS Forum membership, BIO-key will actively participate in a range of initiative

      6/25/25 7:58:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • International Defense Ministry Awards BIO-key over $600K in Follow-On Orders for Secure Biometric Access to Critical Information

      HOLMDEL, N.J., June 17, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB) for phoneless, tokenless, passwordless and phish-resistant authentication experiences, announced that the cyber-defense unit of one of the world's most renowned defense ministries has placed over $600K in new orders for BIO-key's biometric user authentication solution. The orders are for additional biometric hardware and authentication software to be shipped in the current quarter. The defense ministry has deployed BIO-key's biometric authentication solution

      6/17/25 7:58:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • BIO-key and Runlevel Secure First Major IAM Deployment with a National Bank in Mozambique; Extends Growing List of Banking Customers

      LISBON, Portugal and HOLMDEL, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced a strategic partnership with Runlevel, a specialized cybersecurity solutions provider, as well as the partnership's first customer deployment. Runlevel focuses on Portuguese-speaking African countries ("Países Africanos de Língua Oficial Portuguesa or "PALOP") and Timor-Leste in Asia. Runlevel joins BIO-key's Channel Alliance Partner (CAP) program as a Value-Added Reseller (VAR) for businesses and government institutions in PALOP countries and Timor-Leste,

      5/27/25 7:59:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Bio-key upgraded by Maxim Group with a new price target

      Maxim Group upgraded Bio-key from Hold to Buy and set a new price target of $6.00

      3/26/21 7:52:25 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology